336 related articles for article (PubMed ID: 17689092)
1. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
Hulejová H; Baresová V; Klézl Z; Polanská M; Adam M; Senolt L
Cytokine; 2007 Jun; 38(3):151-6. PubMed ID: 17689092
[TBL] [Abstract][Full Text] [Related]
2. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
4. Production of matrix metalloproteinases and their inhibitors in osteoarthritic patients undergoing mud bath therapy.
Bellometti S; Richelmi P; Tassoni T; Bertè F
Int J Clin Pharmacol Res; 2005; 25(2):77-94. PubMed ID: 16060398
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
6. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
8. [Relation between cytokines, adhesive immunoglobulins and matrix metalloproteinases in osteoarthritic joints].
St'ovícková J; Hulejová H; Pesáková V; Spacek P; Klezl Z; Trc T; Adam M
Cas Lek Cesk; 2002 Aug; 141(17):555-60. PubMed ID: 12404960
[TBL] [Abstract][Full Text] [Related]
9. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.
Masuhara K; Nakai T; Yamaguchi K; Yamasaki S; Sasaguri Y
Arthritis Rheum; 2002 Oct; 46(10):2625-31. PubMed ID: 12384920
[TBL] [Abstract][Full Text] [Related]
10. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
11. An inflammation-responsive transcription factor in the pathophysiology of osteoarthritis.
Ray A; Ray BK
Biorheology; 2008; 45(3-4):399-409. PubMed ID: 18836240
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy.
Fiorito S; Magrini L; Adrey J; Mailhé D; Brouty-Boyé D
Rheumatology (Oxford); 2005 Feb; 44(2):164-71. PubMed ID: 15479753
[TBL] [Abstract][Full Text] [Related]
13. Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint.
Maiotti M; Monteleone G; Tarantino U; Fasciglione GF; Marini S; Coletta M
Arthroscopy; 2000; 16(5):522-6. PubMed ID: 10882449
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage.
Julovi SM; Yasuda T; Shimizu M; Hiramitsu T; Nakamura T
Arthritis Rheum; 2004 Feb; 50(2):516-25. PubMed ID: 14872494
[TBL] [Abstract][Full Text] [Related]
15. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders.
Wassilew GI; Lehnigk U; Duda GN; Taylor WR; Matziolis G; Dynybil C
Arthroscopy; 2010 Aug; 26(8):1096-104. PubMed ID: 20678708
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
Klimiuk PA; Sierakowski S; Chwiećko J
Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and inhibitor in knee synovial fluid as cartilage biomarkers in rabbits: the effect of high-intensity jumping exercise.
Qi C; Changlin H; Zefeng H
J Surg Res; 2007 Jun; 140(1):149-57. PubMed ID: 17397871
[TBL] [Abstract][Full Text] [Related]
18. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
[TBL] [Abstract][Full Text] [Related]
19. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
